Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Medanta expanded its bed capacity by 20% during the year
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The target reach is of more than 30 million young people and caregivers across 21 countries
The study has shown that perioperative treatment with Imfinzi (durvalumab), alone or in combination with other immunotherapy agents
Subscribe To Our Newsletter & Stay Updated
